HURRICANE CAPITAL ADVISORS LLC’s Achieve Life Sciences ACHV Stock Holding History

HURRICANE CAPITAL ADVISORS LLC’s Portfolio ACHV Stock Details ACHV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$229K	Sell	35,000 -201,286	-85%	-$960K	0.06%	325
2026 Q1	$695K	Buy	236,286 +171,286	+264%	+$761K	0.22%	92
2025 Q4	$323K	Buy	65,000 +15,000	+30%	+$65.4K	0.1%	163
2025 Q3	$158K	Buy	50,000 +20,000	+67%	+$54.9K	0.04%	361
2025 Q2	$67.8K	Buy	30,000 +10,000	+50%	+$28.5K	0.02%	406
2025 Q1	$53.4K	Buy	20,000 +7,500	+60%	+$23.3K	0.02%	361
2024 Q4	$44K	Sell	12,500 -2,500	-17%	-$11.3K	0.01%	402
2024 Q3	$71.1K	Buy	+15,000	New	+$68.5K	0.03%	396

Other funds holding ACHV

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

HURRICANE CAPITAL ADVISORS LLC's ACHV Position: Q2 2026 in Review

HURRICANE CAPITAL ADVISORS LLC reduced its Achieve Life Sciences (ACHV) stake by 85% in Q2 2026, selling an estimated $960K and leaving 35,000 shares worth $229K. The position accounts for 0.06% of the portfolio, ranked #325.

HURRICANE CAPITAL ADVISORS LLC first reported a position in ACHV in Q3 2024 and has held it in 8 quarters since. The position peaked at $695K in Q1 2026. 112 funds tracked by Wall St. Rank hold ACHV as of Q2 2026.

HURRICANE CAPITAL ADVISORS LLC held 35,000 shares of Achieve Life Sciences worth $229K as of Q2 2026.
HURRICANE CAPITAL ADVISORS LLC sold 201,286 Achieve Life Sciences shares in Q2 2026, an estimated $960K.
Achieve Life Sciences made up 0.06% of HURRICANE CAPITAL ADVISORS LLC's portfolio in Q2 2026, its #325 holding.
HURRICANE CAPITAL ADVISORS LLC first reported a position in Achieve Life Sciences in Q3 2024 and has held it in 8 quarters since.
HURRICANE CAPITAL ADVISORS LLC's Achieve Life Sciences position peaked at $695K in Q1 2026.
112 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2026.

Based on HURRICANE CAPITAL ADVISORS LLC's 13F filing for Q2 2026, filed 3 Nov 2026.